| ADR Ontology |
| ADR Term |
Cerebral toxoplasmosis |
| ADR ID |
BADD_A08330 |
| ADR Hierarchy |
|
| Description |
Infections of the BRAIN caused by the protozoan TOXOPLASMA gondii that primarily arise in individuals with IMMUNOLOGIC DEFICIENCY SYNDROMES (see also AIDS-RELATED OPPORTUNISTIC INFECTIONS). The infection may involve the brain diffusely or form discrete abscesses. Clinical manifestations include SEIZURES, altered mentation, headache, focal neurologic deficits, and INTRACRANIAL HYPERTENSION. (From Joynt, Clinical Neurology, 1998, Ch27, pp41-3) [MeSH] |
| MedDRA Code |
10057854 |
| MeSH ID |
D016781
|
|
ADR Severity Grade (FAERS)
|
|
|
ADR Severity Grade (CTCAE)
|
Not Available
|
| Synonym |
| Encephalitis toxoplasmal | Meningoencephalitis due to toxoplasmosis | Toxoplasma gondii encephalitis | Toxoplasmal encephalitis | Cerebral toxoplasmosis | Toxoplasmic encephalitis recurrent | Toxoplasmosis, Cerebral | Toxoplasmoses, Cerebral | Cerebral Toxoplasmosis | Neurotoxoplasmosis | Toxoplasmosis, Central Nervous System | Central Nervous System Toxoplasmosis | Intracranial Toxoplasmosis | Toxoplasmosis, Intracranial |
|
|
| ADR Related Proteins |
| Protein Name |
UniProt AC |
TTD Target ID |
| Not Available | Not Available | Not Available |
|
| Drugs Leading to the ADR |
| Drug ID | Drug Name | ADR Frequency (FAERS) | ADR Severity Grade (FAERS) | | BADD_D01507 | Mycophenolate mofetil | 0.000853% | | | BADD_D01834 | Prednisone | 0.000021% | | | BADD_D02105 | Tacrolimus | 0.001419% | |
| The 1th Page 1
Total 1 Pages
|
|
